The contributions of risk factor trends to cardiometabolic mortality decline in 26 industrialized countries

被引:60
作者
Di Cesare, Mariachiara [1 ]
Bennett, James E. [1 ]
Best, Nicky [1 ]
Stevens, Gretchen A. [2 ]
Danaei, Goodarz [3 ]
Ezzati, Majid [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, MRC HPA Ctr Environm & Hlth, London, England
[2] World Hlth Org, Dept Hlth Stat & Informat Syst, Geneva, Switzerland
[3] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA
基金
英国医学研究理事会;
关键词
Cardiovascular disease; diabetes; blood pressure; cholesterol; obesity; smoking; CORONARY-HEART-DISEASE; SMOKING-ATTRIBUTABLE MORTALITY; HEALTH EXAMINATION SURVEYS; BLOOD-PRESSURE; SYSTEMATIC ANALYSIS; DEATHS; ASSOCIATIONS; POPULATIONS; PREVALENCE; GLUCOSE;
D O I
10.1093/ije/dyt063
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Cardiovascular disease mortality has declined and diabetes mortality has increased in high-income countries. We estimated the potential role of trends in population body mass index, systolic blood pressure, serum total cholesterol and smoking in cardiometabolic mortality decline in 26 industrialized countries. Methods Mortality data were from national vital statistics. Body mass index, systolic blood pressure and serum total cholesterol were from a systematic analysis of population-based data. We estimated the associations between change in cardiometabolic mortality and changes in risk factors, adjusted for change in per-capita gross domestic product. We calculated the potential contribution of risk factor trends to mortality decline. Results Between 1980 and 2009, age-standardized cardiometabolic mortality declined in all 26 countries, with the annual decline between <1% in Mexico to similar to 5% in Australia. Across the 26 countries together, risk factor trends may have accounted for similar to 48% (men) and similar to 40% (women) of cardiometabolic mortality decline. Risk factor trends may have accounted for >60% of decline among men and women in Finland and Switzerland, men in New Zealand and France, and women in Italy; their benefits were smallest in Mexican, Portuguese, and Japanese men and Mexican women. Risk factor trends may have slowed down mortality decline in Chilean men and women and had virtually no effect in Argentinean women. The contributions of risk factors to mortality decline seemed substantially larger among men than among women in the USA, Canada and The Netherlands. Conclusions Industrialized countries have varied widely in the extent of risk factor prevention, and its likely benefits for cardiometabolic mortality.
引用
收藏
页码:838 / 848
页数:11
相关论文
共 50 条
[21]   Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations [J].
Kuulasmaa, K ;
Tunstall-Pedoe, H ;
Dobson, A ;
Fortmann, S ;
Sans, S ;
Tolonen, H ;
Evans, A ;
Ferrario, M ;
Tuomilehto, J .
LANCET, 2000, 355 (9205) :675-687
[22]   Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies [J].
Law, M. R. ;
Morris, J. K. ;
Wald, N. J. .
BMJ-BRITISH MEDICAL JOURNAL, 2009, 338 :1245
[23]   Trends in mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world [J].
Levi, F ;
Lucchini, F ;
Negri, E ;
La Vecchia, C .
HEART, 2002, 88 (02) :119-124
[24]  
Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171
[25]  
Mathers CD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P45
[26]  
Mhurchu CN, 2006, ASIA PAC J CLIN NUTR, V15, P127
[27]   Improving the comparability of diabetes mortality statistics in the US and Mexico [J].
Murray, Christopher J. L. ;
Dias, Rodrigo H. ;
Kulkarni, Sandeep C. ;
Lozano, Rafael ;
Stevens, Gretchen A. ;
Ezzati, Majid .
DIABETES CARE, 2008, 31 (03) :451-458
[28]   DEATH FROM CARDIOVASCULAR-DISEASE IN ITALY, 1972-1981 - DECLINE IN MORTALITY-RATES AND POSSIBLE CAUSES [J].
NICOLOSI, A ;
CASATI, S ;
TAIOLI, E ;
POLLI, E .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1988, 17 (04) :766-772
[29]   How many deaths are attributable to smoking in the United States? Comparison of methods for estimating smoking-attributable mortality when smoking prevalence changes [J].
Oza, Shefali ;
Thun, Michael J. ;
Henley, S. Jane ;
Lopez, Alan D. ;
Ezzati, Majid .
PREVENTIVE MEDICINE, 2011, 52 (06) :428-433
[30]   The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes [J].
Parving, HH ;
Lehnert, H ;
Bröchner-Mortensen, J ;
Gomis, R ;
Andersen, S ;
Arner, P .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :870-878